Hunan Hansen Pharmaceutical Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Hansen Pharmaceutical Company Limited with three other
companies in this sector in China:
Hubei Guangji Pharmaceutical Co., Ltd.
sales of 801.56 million Chinese Renmimbi [US$116.03 million]
of which 100%
was Pharmaceutical Products),
Qianjiang Yongan Pharmaceutical Co Ltd
(932.77 million Chinese Renmimbi [US$135.03 million]
of which 78%
was Medical Manufacturing), and
Jilin Jian Yisheng Pharmaceutical Company Limited
(1.03 billion Chinese Renmimbi [US$149.75 million]
of which 68%
Hunan Hansen Pharmaceutical Company Limited reported sales of 829.94 million Chinese Renmimbi (US$120.14 million)
December of 2017.
increase of 3.9%
versus 2016, when the company's sales were 798.46 million Chinese Renmimbi.
Sales at Hunan Hansen Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 70%).
Sales of Medical Industry saw an increase
4.1% in 2017, from
796.32 million Chinese Renmimbi to 828.92 million Chinese Renmimbi.
Not all segments of Hunan Hansen Pharmaceutical Company Limited experienced an increase in sales in 2017:
sales of Others fell 52.4% to 1.02 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).